Characterization of the binding of amyloid-β peptide to cell culture- derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

Journal of Neurochemistry

Volumn 68, Issue 2, 1997, Pages 721-725

  Yang, Dun Sheng ^c   Smith, Jonathan D ^a   Zhou, Zhongmin ^b   Gandy, Samuel E ^b   Martins, Ralph N ^c,d  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d HOLLYWOOD PRIVATE HOSPITAL   (Australia)

Author keywords

Alzheimer's disease; Apolipoprotein E isoforms; Apolipoprotein E amyloid complexes; Human plasma; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CHO CELL; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN TISSUE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0031013110     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68020721.x     Document Type: Article

References (18)

1. Das H. K., McPherson J., Bruns G. A., Karathanasis S. K., and Breslow J. L. (1985) Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem. 260, 6240-6247.
2. Emi M., Wu L. L., Robertson M. A., Myers R. L., Hegele R. A., Williams R. R., White R., and Lalouel J. M. (1988) Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 3, 373-379.
3. Hixson J. E. and Vernier D. T. (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J. Lipid Res. 31, 545-548.
4. Hixson J. E., Borenstein L., Cox L. A., Rainwater D. L., and Vande-Berg J. L. (1988) The baboon gene for apolipoprotein A-I: characterization of a cDNA clone and identification of DNA polymorphisms for genetic studies of cholesterol metabolism. Gene 74, 483-490.
5. LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S., and Frail D. E. (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid. J. Biol. Chem. 269, 23403-23406.
6. LaDu M. J., Pederson T. M., Frail D. E., Reardon C. A., Getz G. A., and Falduto M. T. (1995) Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J. Biol. Chem. 270, 9039-9042.
7. Martins R. N., Clarnette R., Fisher C., Broe G. A., Brooks W. S., Montgomery P., and Gandy S. (1995) ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. Neuroreport 6, 1513-1516.
8. Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain Res. 541, 163-166.
9. Rebeck G. W., Reiter J. S., Strickland D. K., and Hyman B. T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580.
10. Schmechel D. E., Saunders A. M., Strittmatter W. J., Crain B. J., Hulette C. M., and Joo S. H. (1993) Increased amyloid beta peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653.
11. Smith J. D., Melian A., Leff T., and Breslow J. L. (1988) Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements. J. Biol. Chem. 263, 8300-8308.
12. Smith J. D., Plump A. S., Hayek T., Walsh A., and Breslow J. L. (1990) Accumulation of human apolipoprotein E in the plasma of transgenic mice. J. Biol. Chem. 265, 14709-14712.
13. Southern P. J. and Berg P. (1982) Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1, 327-341.
14. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M. A., Enghild J., Salvesen G. S., and Roses A. D. (1993a) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad Sci. USA 90, 1977-1981.
15. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L.-M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., and Roses A. D. (1993b) Binding of human apolipoprotein E to synthetic amyloid β peptide. Isoform-specific effects and implications for late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 8098-8102.
16. Wenham P. R., Price W. H., and Blundell G. (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337, 1158-1159.
17. Wisniewski T. and Frangione B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238.
18. Zhou Z., Smith J. D., Greengard P., and Gandy S. (1996) Alzheimer amyloid-β peptide forms denaturant-resistant complex with type ∈3 but not type ∈4 isoform of native apolipoprotein E. Mol. Med. 2, 175-180.